Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |